{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:02:07Z","timestamp":1791352927553,"version":"4.3.1"},"reference-count":110,"publisher":"The Endocrine Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,9,1]]},"abstract":"<jats:p>Prolactin (PRL) is critical for alveolar proliferation and differentiation in normal mammary development and is also implicated in breast cancer. PRL influences cell proliferation and growth by altering the expression of cyclin D1. Cyclin D1 expression is directly regulated by PRL through the Janus kinase 2 (JAK2)\/signal transducer and activator of transcription 5-mediated transcriptional activation of the cyclin D1 promoter. A p21-activated serine-threonine kinase (PAK)1 has also been implicated in the regulation of cyclin D1 gene expression. We have previously demonstrated that JAK2 directly phosphorylates PAK1 and extend these data here to demonstrate that PAK1 activates the cyclin D1 promoter in response to PRL. We show that mutation of PAK1 Tyr 153, 201, and 285 (sites of JAK2 phosphorylation; PAK1 Y3F) decreases both PAK1 nuclear translocation in response to PRL and PRL-induced cyclin D1 promoter activity by 55%. Mutation of the PAK1 nuclear localization signals decreases PRL-induced cyclin D1 promoter activity by 46%. A PAK1 Y3F mutant lacking functional nuclear localization signals decreases PRL-induced cyclin D1 activity by 68%, suggesting that there is another PAK1-dependent mechanism to activate the cyclin D1 promoter. We have found that adapter protein Nck sequesters PAK1 in the cytoplasm and that coexpression of both PAK1 and Nck inhibits the amplifying effect of PRL-induced PAK1 on cyclin D1 promoter activity (95% inhibition). This inhibition is partially abolished by disruption of PAK1-Nck binding. We propose two PAK1-dependent mechanisms to activate cyclin D1 promoter activity in response to PRL: via nuclear translocation of tyrosyl-phosphorylated PAK1 and via formation of a Nck-PAK1 complex that sequesters PAK1 in the cytoplasm.<\/jats:p>","DOI":"10.1210\/me.2011-0062","type":"journal-article","created":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T01:15:04Z","timestamp":1309482904000},"page":"1565-1578","source":"Crossref","is-referenced-by-count":37,"title":["PAK1-Nck Regulates Cyclin D1 Promoter Activity in Response to Prolactin"],"prefix":"10.1210","volume":"25","author":[{"given":"Jing","family":"Tao","sequence":"first","affiliation":[{"name":"Department of Biological Sciences, University of Toledo, Toledo, Ohio 43606-3390"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Oladimeji","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, University of Toledo, Toledo, Ohio 43606-3390"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Rider","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, University of Toledo, Toledo, Ohio 43606-3390"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Diakonova","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, University of Toledo, Toledo, Ohio 43606-3390"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071613301946400_B1","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1210\/er.2004-0016","article-title":"Development and potential clinical uses of human prolactin receptor antagonists.","volume":"26","author":"Goffin","year":"2005","journal-title":"Endocr Rev"},{"key":"2020071613301946400_B2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0303-7207(90)90165-5","article-title":"Prolactin stimulates transcription of growth-related genes in Nb2 T lymphoma cells.","volume":"68","author":"Yu-Lee","year":"1990","journal-title":"Mol Cell Endocrinol"},{"key":"2020071613301946400_B3","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1749-6632.1990.tb40475.x","article-title":"Prolactin-mediated regulation of gene transcription in lymphocytes.","volume":"594","author":"Yu-Lee","year":"1990","journal-title":"Ann NY Acad Sci"},{"key":"2020071613301946400_B4","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.1210\/endo.130.5.1349278","article-title":"Prolactin-stimulated mitogenesis of cultured astrocytes.","volume":"130","author":"DeVito","year":"1992","journal-title":"Endocrinology"},{"key":"2020071613301946400_B5","doi-asserted-by":"crossref","first-page":"5559","DOI":"10.1016\/S0021-9258(17)37498-7","article-title":"Prolactin induces rapid phosphorylation and activation of prolactin receptor-associated RAF-1 kinase in a T-cell line.","volume":"269","author":"Clevenger","year":"1994","journal-title":"J Biol Chem"},{"key":"2020071613301946400_B6","first-page":"674","article-title":"The protein tyrosine kinase P59fyn is associated with prolactin (PRL) receptor and is activated by PRL stimulation of T-lymphocytes.","volume":"8","author":"Clevenger","year":"1994","journal-title":"Mol Endocrinol"},{"key":"2020071613301946400_B7","first-page":"307","article-title":"Prolactin enhances CCAAT enhancer-binding protein-\u03b2 (C\/EBP\u03b2) and peroxisome proliferator-activated receptor \u03b3 (PPAR\u03b3) messenger RNA expression and stimulates adipogenic conversion of NIH-3T3 cells.","volume":"14","author":"Nanbu-Wakao","year":"2000","journal-title":"Mol Endocrinol"},{"key":"2020071613301946400_B8","first-page":"4724","article-title":"Prognostic significance of prolactin receptors in human breast cancer.","volume":"47","author":"Bonneterre","year":"1987","journal-title":"Cancer Res"},{"key":"2020071613301946400_B9","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1210\/jcem.83.2.4564","article-title":"Increased expression of prolactin receptor gene assessed by quantitative polymerase chain reaction in human breast tumors versus normal breast tissues.","volume":"83","author":"Touraine","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613301946400_B10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/er.2001-0036","article-title":"The role of prolactin in mammary carcinoma.","volume":"24","author":"Clevenger","year":"2003","journal-title":"Endocr Rev"},{"key":"2020071613301946400_B11","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1210\/mend.16.1.0762","article-title":"PRL modulates cell cycle regulators in mammary tumor epithelial cells.","volume":"16","author":"Schroeder","year":"2002","journal-title":"Mol Endocrinol"},{"key":"2020071613301946400_B12","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1023\/A:1023956223037","article-title":"Prolactin overexpression by MDA-MB-435 human breast cancer cells accelerates tumor growth.","volume":"79","author":"Liby","year":"2003","journal-title":"Breast Cancer Res Treat"},{"key":"2020071613301946400_B13","first-page":"509","article-title":"Prolactin and heregulin override DNA damage-induced growth arrest and promote phosphatidylinositol-3 kinase-dependent proliferation in breast cancer cells.","volume":"26","author":"Chakravarti","year":"2005","journal-title":"Int J Oncol"},{"key":"2020071613301946400_B14","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1210\/me.2004-0187","article-title":"Multiple kinase cascades mediate prolactin signals to activating protein-1 in breast cancer cells.","volume":"18","author":"Gutzman","year":"2004","journal-title":"Mol Endocrinol"},{"key":"2020071613301946400_B15","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1095\/biolreprod52.5.1187","article-title":"Infertility in transgenic mice overexpressing the bovine growth hormone gene: disruption of the neuroendocrine control of prolactin secretion during pregnancy.","volume":"52","author":"Cecim","year":"1995","journal-title":"Biol Reprod"},{"key":"2020071613301946400_B16","first-page":"2591","article-title":"Prolactin synthesis and secretion by human breast cancer cells.","volume":"55","author":"Ginsburg","year":"1995","journal-title":"Cancer Res"},{"key":"2020071613301946400_B17","first-page":"3583","article-title":"A human prolactin antagonist, hPRL-G129R, inhibits breast cancer cell proliferation through induction of apoptosis.","volume":"5","author":"Chen","year":"1999","journal-title":"Clin Cancer Res"},{"key":"2020071613301946400_B18","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1038\/sj.onc.1203846","article-title":"Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation.","volume":"19","author":"Llovera","year":"2000","journal-title":"Oncogene"},{"key":"2020071613301946400_B19","first-page":"813","article-title":"In vivo studies of the anti-tumor effects of a human prolactin antagonist, hPRL-G129R.","volume":"20","author":"Chen","year":"2002","journal-title":"Int J Oncol"},{"key":"2020071613301946400_B20","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.cytogfr.2007.06.021","article-title":"STAT dynamics.","volume":"18","author":"Reich","year":"2007","journal-title":"Cytokine Growth Factor Rev"},{"key":"2020071613301946400_B21","doi-asserted-by":"crossref","first-page":"20059","DOI":"10.1074\/jbc.R700016200","article-title":"JAK-STAT signaling: from interferons to cytokines.","volume":"282","author":"Schindler","year":"2007","journal-title":"J Biol Chem"},{"key":"2020071613301946400_B22","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1039\/b606246f","article-title":"Structure, function, and regulation of STAT proteins.","volume":"2","author":"Lim","year":"2006","journal-title":"Mol Biosyst"},{"key":"2020071613301946400_B23","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1002\/j.1460-2075.1988.tb03048.x","article-title":"Prolactin regulation of \u03b2-casein gene expression and of a cytosolic 120-kd protein in a cloned mouse mammary epithelial cell line.","volume":"7","author":"Ball","year":"1988","journal-title":"EMBO J"},{"key":"2020071613301946400_B24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0303-7207(95)03738-1","article-title":"Prolactin recruits STAT1, STAT3 and STAT5 independent of conserved receptor tyrosines TYR402, TYR479, TYR515 and TYR580.","volume":"117","author":"DaSilva","year":"1996","journal-title":"Mol Cell Endocrinol"},{"key":"2020071613301946400_B25","first-page":"1914","article-title":"Prolactin activates Stat1 but does not antagonize Stat1 activation and growth inhibition by type I interferons in human breast cancer cells.","volume":"58","author":"Schaber","year":"1998","journal-title":"Cancer Res"},{"key":"2020071613301946400_B26","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1002\/j.1460-2075.1994.tb06495.x","article-title":"Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription factor gene family and confers the prolactin response.","volume":"13","author":"Wakao","year":"1994","journal-title":"EMBO J"},{"key":"2020071613301946400_B27","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1210\/mend.16.4.0817","article-title":"PRL activates the cyclin D1 promoter via the Jak2\/Stat pathway.","volume":"16","author":"Brockman","year":"2002","journal-title":"Mol Endocrinol"},{"key":"2020071613301946400_B28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.mce.2005.04.006","article-title":"Prolactin signals via Stat5 and Oct-1 to the proximal cyclin D1 promoter.","volume":"239","author":"Brockman","year":"2005","journal-title":"Mol Cell Endocrinol"},{"key":"2020071613301946400_B29","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1101\/gad.9.19.2364","article-title":"Mice lacking cyclin D1 are small and show defects in eye and mammary gland development.","volume":"9","author":"Fantl","year":"1995","journal-title":"Genes Dev"},{"key":"2020071613301946400_B30","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0092-8674(95)90034-9","article-title":"Cyclin D1 provides a link between development and oncogenesis in the retina and breast.","volume":"82","author":"Sicinski","year":"1995","journal-title":"Cell"},{"key":"2020071613301946400_B31","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0304-3835(94)03676-A","article-title":"Amplification of chromosome band 11q13 and a role for cyclin D1 in human breast cancer.","volume":"90","author":"Dickson","year":"1995","journal-title":"Cancer Lett"},{"key":"2020071613301946400_B32","first-page":"885","article-title":"Determination of the prognostic value of cyclin D1 overexpression in breast cancer.","volume":"11","author":"McIntosh","year":"1995","journal-title":"Oncogene"},{"key":"2020071613301946400_B33","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/369669a0","article-title":"Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice.","volume":"369","author":"Wang","year":"1994","journal-title":"Nature"},{"key":"2020071613301946400_B34","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1210\/me.2006-0316","article-title":"The Janus kinase 2 is required for expression and nuclear accumulation of cyclin D1 in proliferating mammary epithelial cells.","volume":"21","author":"Sakamoto","year":"2007","journal-title":"Mol Endocrinol"},{"key":"2020071613301946400_B35","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1073\/pnas.90.3.1112","article-title":"Redundant cyclin overexpression and gene amplification in breast cancer cells.","volume":"90","author":"Keyomarsi","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071613301946400_B36","first-page":"163","article-title":"Expression of the G2-M checkpoint regulators cyclin B1 and P34CDC2 in breast cancer: a correlation with cellular kinetics.","volume":"19","author":"Megha","year":"1999","journal-title":"Anticancer Res"},{"key":"2020071613301946400_B37","doi-asserted-by":"crossref","first-page":"30985","DOI":"10.1074\/jbc.M701794200","article-title":"JAK2 tyrosine kinase phosphorylates PAK1 and regulates PAK1 activity and functions.","volume":"282","author":"Rider","year":"2007","journal-title":"J Biol Chem"},{"key":"2020071613301946400_B38","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1146\/annurev.biochem.72.121801.161742","article-title":"Biology of the p21-activated kinases.","volume":"72","author":"Bokoch","year":"2003","journal-title":"Annu Rev Biochem"},{"key":"2020071613301946400_B39","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1042\/BJ20041638","article-title":"PAK and other Rho-associated kinases-effectors with surprisingly diverse mechanisms of regulation.","volume":"386","author":"Zhao","year":"2005","journal-title":"Biochem J"},{"key":"2020071613301946400_B40","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/nrc1892","article-title":"p21-activated kinases in cancer.","volume":"6","author":"Kumar","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"2020071613301946400_B41","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0092-8674(00)00043-X","article-title":"Structure of PAK1 in an autoinhibited conformation reveals a multistage activation switch.","volume":"102","author":"Lei","year":"2000","journal-title":"Cell"},{"key":"2020071613301946400_B42","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1097-2765(01)00428-2","article-title":"Pak1 kinase homodimers are autoinhibited in trans and dissociated upon activation by Cdc42 and Rac1.","volume":"9","author":"Parrini","year":"2002","journal-title":"Mol Cell"},{"key":"2020071613301946400_B43","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/367040a0","article-title":"A brain serine\/threonine protein kinase activated by Cdc42 and Rac1.","volume":"367","author":"Manser","year":"1994","journal-title":"Nature"},{"key":"2020071613301946400_B44","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S1357-2725(98)00059-4","article-title":"The p21Rac\/Cdc42-activated kinases (PAKs).","volume":"30","author":"Knaus","year":"1998","journal-title":"Int J Biochem Cell Biol"},{"key":"2020071613301946400_B45","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1073\/pnas.97.1.185","article-title":"Endogenous, hyperactive Rac3 controls proliferation of breast cancer cells by a p21-activated kinase-dependent pathway.","volume":"97","author":"Mira","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071613301946400_B46","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0960-9822(07)00486-1","article-title":"Distinct cellular effects and interactions of the Rho-family GTPase TC10.","volume":"8","author":"Neudauer","year":"1998","journal-title":"Curr Biol"},{"key":"2020071613301946400_B47","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/S0960-9822(98)70468-3","article-title":"Chp, a homologue of the GTPase Cdc42Hs, activates the JNK pathway and is implicated in reorganizing the actin cytoskeleton.","volume":"8","author":"Aronheim","year":"1998","journal-title":"Curr Biol"},{"key":"2020071613301946400_B48","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1101\/gad.894301","article-title":"Wrch-1, a novel member of the Rho gene family that is regulated by Wnt-1.","volume":"15","author":"Tao","year":"2001","journal-title":"Genes Dev"},{"key":"2020071613301946400_B49","doi-asserted-by":"crossref","first-page":"25746","DOI":"10.1074\/jbc.271.42.25746","article-title":"Interaction of the Nck adapter protein with p21-activated kinase (PAK1).","volume":"271","author":"Bokoch","year":"1996","journal-title":"J Biol Chem"},{"key":"2020071613301946400_B50","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0960-9822(06)00052-2","article-title":"Activation of Pak by membrane localization mediated by an SH3 domain from the adaptor protein Nck.","volume":"7","author":"Lu","year":"1997","journal-title":"Curr Biol"},{"key":"2020071613301946400_B51","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/emboj\/17.3.754","article-title":"Membrane targeting of p21-activated kinase 1 (PAK1) induces neurite outgrowth from PC12 cells.","volume":"17","author":"Daniels","year":"1998","journal-title":"EMBO J"},{"key":"2020071613301946400_B52","doi-asserted-by":"crossref","first-page":"6354","DOI":"10.1128\/MCB.20.17.6354-6363.2000","article-title":"Coupling of PAK-interacting exchange factor PIX to GIT1 promotes focal complex disassembly.","volume":"20","author":"Zhao","year":"2000","journal-title":"Mol Cell Biol"},{"key":"2020071613301946400_B53","doi-asserted-by":"crossref","first-page":"41201","DOI":"10.1074\/jbc.M006553200","article-title":"p21-activated kinase (PAK1) is phosphorylated and activated by 3-phosphoinositide-dependent kinase-1 (PDK1).","volume":"275","author":"King","year":"2000","journal-title":"J Biol Chem"},{"key":"2020071613301946400_B54","doi-asserted-by":"crossref","first-page":"8137","DOI":"10.1074\/jbc.273.14.8137","article-title":"A GTPase-independent mechanism of p21-activated kinase activation. Regulation by sphingosine and other biologically active lipids.","volume":"273","author":"Bokoch","year":"1998","journal-title":"J Biol Chem"},{"key":"2020071613301946400_B55","doi-asserted-by":"crossref","first-page":"9106","DOI":"10.1074\/jbc.275.13.9106","article-title":"The Akt proto-oncogene links Ras to Pak and cell survival signals.","volume":"275","author":"Tang","year":"2000","journal-title":"J Biol Chem"},{"key":"2020071613301946400_B56","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1128\/MCB.20.11.3906-3917.2000","article-title":"Interaction between PAK and nck: a template for Nck targets and role of PAK autophosphorylation.","volume":"20","author":"Zhao","year":"2000","journal-title":"Mol Cell Biol"},{"key":"2020071613301946400_B57","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/26034","article-title":"The p35\/Cdk5 kinase is a neuron-specific Rac effector that inhibits Pak1 activity.","volume":"395","author":"Nikolic","year":"1998","journal-title":"Nature"},{"key":"2020071613301946400_B58","doi-asserted-by":"crossref","first-page":"49043","DOI":"10.1074\/jbc.M105599200","article-title":"Phosphorylation of Pak1 by the p35\/Cdk5 kinase affects neuronal morphology.","volume":"276","author":"Rashid","year":"2001","journal-title":"J Biol Chem"},{"key":"2020071613301946400_B59","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1016\/S0960-9822(02)00931-4","article-title":"Cell cycle-regulated phosphorylation of p21-activated kinase 1.","volume":"12","author":"Thiel","year":"2002","journal-title":"Curr Biol"},{"key":"2020071613301946400_B60","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/S0960-9822(02)00956-9","article-title":"Pak1 phosphorylation on t212 affects microtubules in cells undergoing mitosis.","volume":"12","author":"Banerjee","year":"2002","journal-title":"Curr Biol"},{"key":"2020071613301946400_B61","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1128\/MCB.17.3.1129","article-title":"Expression of constitutively active \u03b1-PAK reveals effects of the kinase on actin and focal complexes.","volume":"17","author":"Manser","year":"1997","journal-title":"Mol Cell Biol"},{"key":"2020071613301946400_B62","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/ncb838","article-title":"Filamin is essential in actin cytoskeletal assembly mediated by p21-activated kinase 1.","volume":"4","author":"Vadlamudi","year":"2002","journal-title":"Nat Cell Biol"},{"key":"2020071613301946400_B63","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1038\/sj.onc.1209983","article-title":"The kinase-inhibitory domain of p21-activated kinase 1 (PAK1) inhibits cell cycle progression independent of PAK1 kinase activity.","volume":"26","author":"Thullberg","year":"2007","journal-title":"Oncogene"},{"key":"2020071613301946400_B64","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/jcp.10167","article-title":"Emerging functions of p21-activated kinases in human cancer cells.","volume":"193","author":"Kumar","year":"2002","journal-title":"J Cell Physiol"},{"key":"2020071613301946400_B65","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/bcr961","article-title":"p21-activated kinase signaling in breast cancer.","volume":"7","author":"Gururaj","year":"2005","journal-title":"Breast Cancer Res"},{"key":"2020071613301946400_B66","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000134699","article-title":"Detailed map of a region commonly amplified at 11q13-&gt;q14 in human breast carcinoma.","volume":"79","author":"Bekri","year":"1997","journal-title":"Cytogenet Cell Genet"},{"key":"2020071613301946400_B67","doi-asserted-by":"crossref","first-page":"36238","DOI":"10.1074\/jbc.M002138200","article-title":"Regulatable expression of p21-activated kinase-1 promotes anchorage-independent growth and abnormal organization of mitotic spindles in human epithelial breast cancer cells.","volume":"275","author":"Vadlamudi","year":"2000","journal-title":"J Biol Chem"},{"key":"2020071613301946400_B68","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/ijc.10147","article-title":"Dysregulation of phosphatidylinositol 3-kinase and downstream effectors in human breast cancer.","volume":"98","author":"Salh","year":"2002","journal-title":"Int J Cancer"},{"key":"2020071613301946400_B69","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1074\/jbc.M309937200","article-title":"p21-activated kinase-1 signaling mediates cyclin D1 expression in mammary epithelial and cancer cells.","volume":"279","author":"Balasenthil","year":"2004","journal-title":"J Biol Chem"},{"key":"2020071613301946400_B70","doi-asserted-by":"crossref","first-page":"12041","DOI":"10.1074\/jbc.275.16.12041","article-title":"Regulation of microfilament reorganization and invasiveness of breast cancer cells by kinase dead p21-activated kinase-1.","volume":"275","author":"Adam","year":"2000","journal-title":"J Biol Chem"},{"key":"2020071613301946400_B71","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ccr.2004.05.022","article-title":"Dynein light chain 1, a p21-activated kinase 1-interacting substrate, promotes cancerous phenotypes.","volume":"5","author":"Vadlamudi","year":"2004","journal-title":"Cancer Cell"},{"key":"2020071613301946400_B72","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/jnci\/djj185","article-title":"Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients.","volume":"98","author":"Holm","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"2020071613301946400_B73","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1158\/0008-5472.CAN-05-2922","article-title":"P21-activated kinase 1 regulation of estrogen receptor-\u03b1 activation involves serine 305 activation linked with serine 118 phosphorylation.","volume":"66","author":"Rayala","year":"2006","journal-title":"Cancer Res"},{"key":"2020071613301946400_B74","doi-asserted-by":"crossref","first-page":"18130","DOI":"10.1074\/jbc.M412607200","article-title":"Nuclear localization and chromatin targets of p21-activated kinase 1.","volume":"280","author":"Singh","year":"2005","journal-title":"J Biol Chem"},{"key":"2020071613301946400_B75","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1093\/embo-reports\/kvf157","article-title":"p21-activated kinase 1 interacts with and phosphorylates histone H3 in breast cancer cells.","volume":"3","author":"Li","year":"2002","journal-title":"EMBO Rep"},{"key":"2020071613301946400_B76","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/j.1471-4159.2006.04263.x","article-title":"JNK- and Rac1-dependent induction of immediate early gene pip92 suppresses neuronal differentiation.","volume":"100","author":"Park","year":"2007","journal-title":"J Neurochem"},{"key":"2020071613301946400_B77","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.biopha.2007.05.006","article-title":"Sliding p21-activated kinase 1 to nucleus impacts tamoxifen sensitivity.","volume":"61","author":"Rayala","year":"2007","journal-title":"Biomed Pharmacother"},{"key":"2020071613301946400_B78","doi-asserted-by":"crossref","first-page":"20997","DOI":"10.1074\/jbc.271.35.20997","article-title":"The adaptor protein Nck links receptor tyrosine kinases with the serine-threonine kinase Pak1.","volume":"271","author":"Galisteo","year":"1996","journal-title":"J Biol Chem"},{"key":"2020071613301946400_B79","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.cell.2007.06.053","article-title":"Septins regulate actin organization and cell-cycle arrest through nuclear accumulation of NCK mediated by SOCS7.","volume":"130","author":"Kremer","year":"2007","journal-title":"Cell"},{"key":"2020071613301946400_B80","doi-asserted-by":"crossref","first-page":"F951","DOI":"10.1152\/ajprenal.00536.2009","article-title":"p21-activated kinases regulate actin remodeling in glomerular podocytes.","volume":"298","author":"Zhu","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"2020071613301946400_B81","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1128\/MCB.17.3.1324","article-title":"Rac regulation of transformation, gene expression, and actin organization by multiple, PAK-independent pathways.","volume":"17","author":"Westwick","year":"1997","journal-title":"Mol Cell Biol"},{"key":"2020071613301946400_B82","doi-asserted-by":"crossref","first-page":"2384","DOI":"10.1128\/MCB.25.6.2384-2394.2005","article-title":"The NF2 tumor suppressor gene product, merlin, inhibits cell proliferation and cell cycle progression by repressing cyclin D1 expression.","volume":"25","author":"Xiao","year":"2005","journal-title":"Mol Cell Biol"},{"key":"2020071613301946400_B83","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4161\/cc.3.1.593","article-title":"PAK is essential for RAS-induced upregulation of cyclin D1 during the G1 to S transition.","volume":"3","author":"Nheu","year":"2004","journal-title":"Cell Cycle"},{"key":"2020071613301946400_B84","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/sj.onc.1200821","article-title":"The Nck SH2\/SH3 adaptor protein is present in the nucleus and associates with the nuclear protein SAM68.","volume":"14","author":"Lawe","year":"1997","journal-title":"Oncogene"},{"key":"2020071613301946400_B85","doi-asserted-by":"crossref","first-page":"5834","DOI":"10.1128\/MCB.12.12.5834","article-title":"The SH2- and SH3-containing Nck protein transforms mammalian fibroblasts in the absence of elevated phosphotyrosine levels.","volume":"12","author":"Chou","year":"1992","journal-title":"Mol Cell Biol"},{"key":"2020071613301946400_B86","doi-asserted-by":"crossref","first-page":"5824","DOI":"10.1128\/MCB.12.12.5824","article-title":"The SH2 and SH3 domain-containing Nck protein is oncogenic and a common target for phosphorylation by different surface receptors.","volume":"12","author":"Li","year":"1992","journal-title":"Mol Cell Biol"},{"key":"2020071613301946400_B87","doi-asserted-by":"crossref","first-page":"5816","DOI":"10.1128\/MCB.12.12.5816","article-title":"Phosphorylation of Nck in response to a variety of receptors, phorbol myristate acetate, and cyclic AMP.","volume":"12","author":"Park","year":"1992","journal-title":"Mol Cell Biol"},{"key":"2020071613301946400_B88","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0014-5793(03)00424-1","article-title":"PAK interacts with NCK and MLK2 to regulate the activation of jun N-terminal kinase.","volume":"543","author":"Poitras","year":"2003","journal-title":"FEBS Lett"},{"key":"2020071613301946400_B89","doi-asserted-by":"crossref","first-page":"32781","DOI":"10.1074\/jbc.M202336200","article-title":"Role of Dok1 in cell signaling mediated by RET tyrosine kinase.","volume":"277","author":"Murakami","year":"2002","journal-title":"J Biol Chem"},{"key":"2020071613301946400_B90","doi-asserted-by":"crossref","first-page":"34336","DOI":"10.1074\/jbc.M402767200","article-title":"The adaptor protein Nck1 mediates endothelin A receptor-regulated cell migration through the Cdc42-dependent c-Jun N-terminal kinase pathway.","volume":"279","author":"Miyamoto","year":"2004","journal-title":"J Biol Chem"},{"key":"2020071613301946400_B91","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1128\/MCB.20.5.1537-1545.2000","article-title":"Nck-interacting Ste20 kinase couples Eph receptors to c-Jun N-terminal kinase and integrin activation.","volume":"20","author":"Becker","year":"2000","journal-title":"Mol Cell Biol"},{"key":"2020071613301946400_B92","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1074\/jbc.273.3.1303","article-title":"Nck recruitment to Eph receptor, EphB1\/ELK, couples ligand activation to c-Jun kinase.","volume":"273","author":"Stein","year":"1998","journal-title":"J Biol Chem"},{"key":"2020071613301946400_B93","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1093\/emboj\/16.6.1279","article-title":"NIK is a new Ste20-related kinase that binds NCK and MEKK1 and activates the SAPK\/JNK cascade via a conserved regulatory domain.","volume":"16","author":"Su","year":"1997","journal-title":"EMBO J"},{"key":"2020071613301946400_B94","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/1-4020-7847-1_11","article-title":"Signal transduction mediated by cyclin D1: from mitogens to cell proliferation: a molecular target with therapeutic potential.","volume":"119","author":"Wang","year":"2004","journal-title":"Cancer Treat Res"},{"key":"2020071613301946400_B95","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/08977190500361812","article-title":"Cyclins: roles in mitogenic signaling and oncogenic transformation.","volume":"24","author":"Musgrove","year":"2006","journal-title":"Growth Factors"},{"key":"2020071613301946400_B96","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0898-6568(02)00027-X","article-title":"The Nck family of adapter proteins: regulators of actin cytoskeleton.","volume":"14","author":"Buday","year":"2002","journal-title":"Cell Signal"},{"key":"2020071613301946400_B97","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1210\/mend.15.12.0743","article-title":"The protein tyrosine phosphatase-PEST is implicated in the negative regulation of epidermal growth factor on PRL signaling in mammary epithelial cells.","volume":"15","author":"Horsch","year":"2001","journal-title":"Mol Endocrinol"},{"key":"2020071613301946400_B98","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1210\/mend.11.9.9980","article-title":"Phosphorylation of cbl after stimulation of Nb2 cells with prolactin and its association with phosphatidylinositol 3-kinase.","volume":"11","author":"Hunter","year":"1997","journal-title":"Mol Endocrinol"},{"key":"2020071613301946400_B99","doi-asserted-by":"crossref","first-page":"3590","DOI":"10.1210\/en.2002-220374","article-title":"c-Cbl is a negative regulator of GH-stimulated STAT5-mediated transcription.","volume":"143","author":"Goh","year":"2002","journal-title":"Endocrinology"},{"key":"2020071613301946400_B100","doi-asserted-by":"crossref","first-page":"5346","DOI":"10.1038\/sj.onc.1205670","article-title":"Repression of c-Cbl leads to enhanced G-CSF Jak-STAT signaling without increased cell proliferation.","volume":"21","author":"Wang","year":"2002","journal-title":"Oncogene"},{"key":"2020071613301946400_B101","doi-asserted-by":"crossref","first-page":"17363","DOI":"10.1016\/S0021-9258(17)32443-2","article-title":"Physical association between Src homology 3 elements and the protein product of the c-cbl proto-oncogene.","volume":"269","author":"Rivero-Lezcano","year":"1994","journal-title":"J Biol Chem"},{"key":"2020071613301946400_B102","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0898-6568(98)00054-0","article-title":"Requirement of multiple SH3 domains of Nck for ligand binding.","volume":"11","author":"Wunderlich","year":"1999","journal-title":"Cell Signal"},{"key":"2020071613301946400_B103","doi-asserted-by":"crossref","first-page":"37662","DOI":"10.1074\/jbc.M404007200","article-title":"Tyrosine-phosphorylated SOCS3 interacts with the Nck and Crk-L adapter proteins and regulates Nck activation.","volume":"279","author":"Sitko","year":"2004","journal-title":"J Biol Chem"},{"key":"2020071613301946400_B104","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0303-7207(99)00180-X","article-title":"SOCS-1, -2, -3: selective targets and functions downstream of the prolactin receptor.","volume":"158","author":"Tomic","year":"1999","journal-title":"Mol Cell Endocrinol"},{"key":"2020071613301946400_B105","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.1210\/endo.142.12.8549","article-title":"Cytokine-inducible SH2-containing protein suppresses PRL signaling by binding the PRL receptor.","volume":"142","author":"Dif","year":"2001","journal-title":"Endocrinology"},{"key":"2020071613301946400_B106","doi-asserted-by":"crossref","first-page":"29338","DOI":"10.1074\/jbc.M003456200","article-title":"CIS3\/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2.","volume":"275","author":"Sasaki","year":"2000","journal-title":"J Biol Chem"},{"key":"2020071613301946400_B107","first-page":"2105","article-title":"Inducible regulatory elements in the human cyclin D1 promoter.","volume":"9","author":"Herber","year":"1994","journal-title":"Oncogene"},{"key":"2020071613301946400_B108","doi-asserted-by":"crossref","first-page":"10669","DOI":"10.1074\/jbc.M111138200","article-title":"SH2-B\u03b2 is a Rac-binding protein that regulates cell motility.","volume":"277","author":"Diakonova","year":"2002","journal-title":"J Biol Chem"},{"key":"2020071613301946400_B109","doi-asserted-by":"crossref","first-page":"11970","DOI":"10.1074\/jbc.M210765200","article-title":"YXXL motifs in SH2-B\u03b2 are phosphorylated by JAK2, JAK1, and platelet-derived growth factor receptor and are required for membrane ruffling.","volume":"278","author":"O'Brien","year":"2003","journal-title":"J Biol Chem"},{"key":"2020071613301946400_B110","doi-asserted-by":"crossref","first-page":"4701","DOI":"10.1016\/S0021-9258(17)37599-3","article-title":"Growth hormone induces a DNA binding factor related to the interferon-stimulated 91-kDa transcription factor.","volume":"269","author":"Meyer","year":"1994","journal-title":"J Biol Chem"}],"container-title":["Molecular Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/mend\/article-pdf\/25\/9\/1565\/8932135\/mend1565.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/mend\/article-pdf\/25\/9\/1565\/8932135\/mend1565.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,27]],"date-time":"2021-11-27T07:38:03Z","timestamp":1637998683000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/mend\/article\/25\/9\/1565\/2614808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9,1]]},"references-count":110,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2011,9,1]]}},"URL":"https:\/\/doi.org\/10.1210\/me.2011-0062","relation":{},"ISSN":["0888-8809","1944-9917"],"issn-type":[{"value":"0888-8809","type":"print"},{"value":"1944-9917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,9,1]]}}}